Kirstin Dawson

Service Line Specialist, Pharma & Biopharmaceuticals (Apr '20 - Sept '24)

Directed strategic sales initiatives for digital solutions, enhancing client portfolios for 5-8 core strategic accounts, while also overseeing additional expansion and new-business accounts.

• Closed multi-year digital transformation programs ranging from $500k-$5M+, spanning design, engineering, marketing technology, modern workplace, and digital learning solutions.
• Exceeded annual sales quotas of $20M+ by driving multi-year, high-value engagements, achieving 100%–175% of targets across multiple fiscal years.
• Led RFI/RFP and proposal development process, including deal construction, profitability analysis, and contract negotiations.
• Collaborated with internal teams to craft value-driven solutions and account growth strategies.

Oversaw business development and client services of all west coast accounts for pharma and biopharmaceutical clients in need of brand and corporate strategy and development.

• Drove expansion of west coast accounts, leading full-cycle sales from discovery to contract execution, and project delivery.
• Expanded territory pipeline, generating $3.2M in new business within 24 months.
• Spearheaded the design and company-wide adoption of a new business development and services delivery model, uniting BD, Account, and Client Services teams under a streamlined, high-impact operating structure.
• Orchestrated cross-functional team of ~65 Syneos Health west coast based colleagues across 11 business units to foster and deepen collaboration of clinical, consulting, and communication services, creating greater efficiencies.

Managed 2nd largest AOR account, the U.S. launch of an antibiotic indicated for community acquired bacterial pneumonia (Cempra Pharmaceuticals). Included strategic and creative development of disease awareness HCP campaign, pre-launch and launch of HCP branded campaign, all digital tactics, and media.

• Expanded strategic partnership with client, increasing annual SOW by $1 million (+20%) through program enhancements and generation of new initiatives.
• Drove agency marketing efforts for U.S. launches of XIGDUO XR (AstraZeneca) and NATPARA (Shire), developing and executing pre-launch and launch strategy and tactical plans for multichannel and digital initiatives, including comprehensive CRM campaigns, website design and build, and social media.

Led development and delivery of HCP multichannel, digital strategic and tactical initiatives, including site design, PRM program, sales rep communications programs, and online media.

• Launched ELIQUIS (Bristol-Myers Squibb and Pfizer, JV) NVAF indication and developed pre-launch and launch tactical plan for future VTE indications.
• Conducted quarterly and monthly requisitions, direct hours analysis reporting and billing.

Acct Supervisor (’10 - ’11), Sr. Acct Executive (’09 - ’10), Acct Executive (’08 - ’09)

• Led agency HCP U.S. tactical planning for LYRICA DPN Indication (Pfizer).
• Served as long-standing AOR account lead to TYSABRI (Biogen Idec) HCP U.S. and Global teams. Drove daily workflow and execution of concurrent projects, ensuring all deliverables were completed on time, on strategy, and on budget.
• Spearheaded various key achievements for the TYSABRI brand, including the strategic and creative global brand relaunch, design of first interactive congress meeting booth/experience, and the development and launch of the first multichannel, multi-award winning, disruptive unbranded campaign in multiple sclerosis.